Back

Hepatitis E in Kathmandu Valley: Insights from a Representative Longitudinal Serosurvey

Katuwal, N.; Thapa, M.; Shrestha, S.; Vaidya, K.; Bogoch, I. I.; Andrews, J. R.; Shrestha, R.; Tamrakar, D.; Aiemjoy, K.

2023-11-29 epidemiology
10.1101/2023.11.28.23299131 medRxiv
Show abstract

Hepatitis-E virus (HEV), an etiologic agent of acute inflammatory liver disease, is a significant cause of morbidity and mortality in South Asia. HEV is considered endemic in Nepal; but data on population-level infection transmission is sparse. We conducted a representative longitudinal serologic study between February 2019 and April 2021 in urban and peri-urban areas of central Nepal to characterize community-level HEV transmission. Individuals were followed up to four times, during which capillary blood samples were collected on dried blood spots and tested for anti-HEV immunoglobulin-G antibodies. Analyzing 2513 dried blood samples from 923 participants aged 0-25 years, we found a seroprevalence of 4.8% and a seroincidence rate of 10.9 per 1000 person-years. Notably, young adults, including women of childbearing age, faced the highest incidence of infection. Geospatial analysis identified potential HEV clusters in Kavre and Kathmandu districts, emphasizing the need for targeted interventions. Water source played a crucial role in HEV transmission, with individuals consuming surface water facing the highest risk of seroconversion. Our findings underscore the endemic nature of HEV in Nepal, emphasizing the importance of safe water practices and potential vaccination strategies for high-risk groups.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.